🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to evaluate the efficacy of BIIB104 i...
Status
Completed
Location
Pillar Clinical Research, LLC
Start Date
2018-11-15
Trial ID
NCT03745820
The primary objective of this study will evaluate the safety and tolerabili...
Status
Completed
Location
Research Site
Start Date
2010-07-15
Trial ID
NCT01159483
Treatments Being Tested
To assess if PF-04958242 can attenuate the ketamine-induced cognitive impai...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-12
Trial ID
NCT01749098
Treatments Being Tested
The purpose of the current study is to characterize the pharmacokinetic (PK...
Status
Completed
Location
Pfizer New Haven Clinical Research Unit
Start Date
2015-02-05
Trial ID
NCT02341482
Treatments Being Tested
This study aims to assess the safety, tolerability, and pharmacokinetics of...
Status
Completed
Location
New Haven Clinical Research Unit
Start Date
2014-09-22
Trial ID
NCT02228395
Treatments Being Tested
The purpose of this study is to determine whether PF-04958242 is safe and e...
Status
Terminated
Location
Collaborative Neuroscience Network, LLC (Investigator Site File Location)
Start Date
2016-08-29
Trial ID
NCT02855411
Treatments Being Tested
The primary objective is to evaluate the pharmacokinetics (PK) of BIIB104 i...
Status
Completed
Location
Research Site
Start Date
2019-10-02
Trial ID
NCT04079101
The objective of this study is to examine the safety, tolerability, and eff...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-12
Trial ID
NCT01518920
Treatments Being Tested
The primary objective of this study aims to determine whether the drug affe...
Status
Completed
Location
Research Site
Start Date
2011-06-24
Trial ID
NCT01365338
Treatments Being Tested
This study aims to assess the safety, tolerability, and pharmacokinetics of...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-06
Trial ID
NCT01511510
Treatments Being Tested